Treace Medical Concepts Inc. Gains 35.07%
Wed, Nov 06, 2024 at 07:29 PM
Treace Medical Concepts Inc. (TMCI:NASDAQ) shot up at $7.78, representing a gain of 35.1%. On Wed, Nov 06, 2024, TMCI:NASDAQ touched a New 2-Week High of $7.78. The stock got featured on our News Catalysts scanner on Wed, Nov 06, 2024 at 03:20 AM in the 'MISCELLANEOUS' category. From Wed, Oct 23, 2024, the stock recorded 50.00% Up Days and 36.36% Green Days
About Treace Medical Concepts Inc. (TMCI:NASDAQ)
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities.
Top 10 Gainers:
- SRAX, Inc. (SRAX:NASDAQ), 2841.18%
- FOXO Technologies Inc. Class A (FOXO:NYSEMKT), 475.02%
- Trilogy Metals Inc. (TMQ:NYSEMKT), 79.26%
- FREYR Battery (FREY:NYSE), 66.67%
- ARB IOT Group Limited (ARBB:NASDAQ), 44.09%
- Earlyworks Co. Ltd. (ELWS:NASDAQ), 43.29%
- The GEO Group, Inc. (GEO:NYSE), 42.1%
- Destiny Tech100 Inc. (DXYZ:NYSE), 37.1%
- Cytek Biosciences Inc. (CTKB:NASDAQ), 36.03%
- Treace Medical Concepts Inc. (TMCI:NASDAQ), 35.07%